Line 3:
Line 3:
==Description==
==Description==
+
One of the most common causes of an acquired coagulopathy
+
in dogs is the accidental ingestion of an anticoagulant
+
rodenticide. The first generatlion
+
coumarin-derivative anticoagulant,
+
warfarin. has a short half-life
+
of about 12 hours and a relatively
+
low toxicity in non-target species.
+
Therefore, repeated or massive exposure
+
would generally be required to
+
produce clinical bleeding in a dog.
+
The second generation coumarin
+
derivatives (bromadiolone and brodifacoum)
+
and indandione rodenticides
+
(pindone and diaphacinone), developed
+
in response to wartarin resistance
+
in target species, are tar more
+
potent than warfarin. They have much
+
longer lasting etfects (half-lives of
+
four to six days) as they are more
+
completely bound to plasmla proteins
+
and, compared to warfarin, have an
+
enhanced tendency to accumulate in
+
hepatic tissue. Secondary poisoning
+
through ingestion ol killed target
+
species is more likely to occur with
+
these latter agents.
+
The coumarin derivatives exert interaction of
+
their anticoagulant eftect by inhibiting the enzyme, vitamin K epoxide reductase (see box on page 63). This enizymiie is a component of
+
the vitamin K epoxide cycle required tf)r hepatic synthesis
+
of the functional clotting factors F-II, F-VII, F-IX and
+
F-X. Inhibition of the enzyme causes the accumulation of the inactive vitamin K epoxide and prevents the carboxylation
+
of vitamin K-dependent coagulation proteins. The
+
acarboxy precursor proteins are incapable of being activated
+
during the coagulation process and thus cannot
+
actively participate in fibrin formation.
==Signalment==
==Signalment==